Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (191-200 of 785) with videos related to

Pageof 79
Sort By:
Innere Medizin (Heidelberg, Germany)|June 2, 2026
[Surrogate markers in chronic kidney disease : Estimated glomerular filtration rate and albuminuria in clinical practice and in studies]Jan Galle, Thomas Ebert, Martina Guthoff, et al.
Plos One|February 18, 2017
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis RegistryHansjörg Rothe, Vincent Brandenburg, Margot Haun, et al.
BMC Nephrology|November 30, 2014
Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry diseaseMartin Wagner, Johannes Krämer, Elisabeth Blohm, et al.
European Journal of Pediatrics|November 4, 2005
Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boyAndreas O Eggert, Rupert Wössner, Anita Knoll, et al.
Clinical Nephrology|December 11, 2025
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysisNicolaus Mussmaecher, Steffen Mitzner, Christian Haas, et al.
Plos One|November 17, 2016
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry DiseaseNurcan Üçeyler, Nils Schröter, Waldemar Kafke, et al.
Molecular Genetics & Genomic Medicine|August 16, 2022
X-chromosomal inactivation patterns in women with Fabry diseaseLaura Wagenhäuser, Vanessa Rickert, Claudia Sommer, et al.
BMC Nephrology|March 26, 2013
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetesAndreas Schneider, Markus P Schneider, Hubert Scharnagl, et al.
Journal of the American Society of Nephrology : JASN|March 19, 2011
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitusWiebke Fenske, Christoph Wanner, Bruno Allolio, et al.
NDT Plus|January 20, 2011
The 2008 ERA-EDTA Registry Annual Report-a précisVianda S Stel, Moniek W M van de Luijtgaarden, Christoph Wanner, et al.
Pageof 79

Showing results (191-200 of 785) with videos related to

Sort By:
Pageof 79
Innere Medizin (Heidelberg, Germany)|June 2, 2026
[Surrogate markers in chronic kidney disease : Estimated glomerular filtration rate and albuminuria in clinical practice and in studies]Jan Galle, Thomas Ebert, Martina Guthoff, et al.
Plos One|February 18, 2017
Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients - Data from the German Calciphylaxis RegistryHansjörg Rothe, Vincent Brandenburg, Margot Haun, et al.
BMC Nephrology|November 30, 2014
Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry diseaseMartin Wagner, Johannes Krämer, Elisabeth Blohm, et al.
European Journal of Pediatrics|November 4, 2005
Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boyAndreas O Eggert, Rupert Wössner, Anita Knoll, et al.
Clinical Nephrology|December 11, 2025
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysisNicolaus Mussmaecher, Steffen Mitzner, Christian Haas, et al.
Plos One|November 17, 2016
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry DiseaseNurcan Üçeyler, Nils Schröter, Waldemar Kafke, et al.
Molecular Genetics & Genomic Medicine|August 16, 2022
X-chromosomal inactivation patterns in women with Fabry diseaseLaura Wagenhäuser, Vanessa Rickert, Claudia Sommer, et al.
BMC Nephrology|March 26, 2013
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetesAndreas Schneider, Markus P Schneider, Hubert Scharnagl, et al.
Journal of the American Society of Nephrology : JASN|March 19, 2011
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitusWiebke Fenske, Christoph Wanner, Bruno Allolio, et al.
NDT Plus|January 20, 2011
The 2008 ERA-EDTA Registry Annual Report-a précisVianda S Stel, Moniek W M van de Luijtgaarden, Christoph Wanner, et al.
Pageof 79